NIGI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.575
EU - Europa 4.063
AS - Asia 1.906
SA - Sud America 257
AF - Africa 42
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.859
Nazione #
US - Stati Uniti d'America 5.534
RU - Federazione Russa 1.001
IT - Italia 847
SG - Singapore 679
CN - Cina 650
GB - Regno Unito 644
IE - Irlanda 553
SE - Svezia 245
BR - Brasile 215
UA - Ucraina 174
HK - Hong Kong 168
DE - Germania 153
FR - Francia 119
FI - Finlandia 111
KR - Corea 104
VN - Vietnam 102
IN - India 65
ES - Italia 59
NL - Olanda 35
BE - Belgio 29
TR - Turchia 22
AT - Austria 20
BD - Bangladesh 20
CA - Canada 20
PK - Pakistan 20
MX - Messico 17
CZ - Repubblica Ceca 14
AR - Argentina 12
AU - Australia 12
IR - Iran 12
IQ - Iraq 11
JP - Giappone 11
EC - Ecuador 10
GR - Grecia 10
ZA - Sudafrica 10
SA - Arabia Saudita 9
EG - Egitto 7
PL - Polonia 7
LT - Lituania 6
CH - Svizzera 5
MA - Marocco 5
RO - Romania 5
VE - Venezuela 5
AL - Albania 4
AM - Armenia 4
CI - Costa d'Avorio 4
CL - Cile 4
IL - Israele 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DK - Danimarca 3
DZ - Algeria 3
LU - Lussemburgo 3
NG - Nigeria 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
BY - Bielorussia 2
EU - Europa 2
GY - Guiana 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
TN - Tunisia 2
UG - Uganda 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
ID - Indonesia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
OM - Oman 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SX - ???statistics.table.value.countryCode.SX??? 1
TW - Taiwan 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 11.859
Città #
Dallas 1.706
Southend 557
Dublin 549
Fairfield 525
Ashburn 419
Singapore 403
Moscow 287
Woodbridge 252
Chandler 251
Santa Clara 239
Houston 227
Seattle 210
Siena 200
Cambridge 187
Beijing 184
Wilmington 171
Hong Kong 168
Jacksonville 139
Hefei 124
Seoul 103
Florence 98
New York 87
Ann Arbor 79
Princeton 74
Munich 66
Los Angeles 64
Helsinki 61
Dong Ket 52
Milan 52
Nanjing 45
Málaga 40
Shanghai 38
San Diego 35
The Dalles 31
Rome 26
Boardman 25
San Mateo 23
Buffalo 22
Council Bluffs 21
São Paulo 21
Turku 19
Washington 19
Bengaluru 18
Ho Chi Minh City 18
Dearborn 17
London 16
Nanchang 16
Columbus 15
Lauterbourg 15
Phoenix 15
Changsha 14
Leuven 14
Lappeenranta 13
Chennai 12
Fremont 12
Nuremberg 12
Portsmouth 12
Redondo Beach 12
Brno 11
Chicago 11
Shenyang 11
Stockholm 11
Zhengzhou 11
Frankfurt am Main 10
Guangzhou 10
Montreal 10
Norwalk 10
Pisa 10
San Francisco 10
Verona 10
Vienna 10
Brooklyn 9
Hanoi 9
Izmir 9
Jiaxing 9
Kraainem 9
Lahore 9
Toronto 9
Turin 9
Atlanta 8
Boston 8
Enfield 8
Karachi 8
Mexico City 8
Redmond 8
Baghdad 7
Belo Horizonte 7
Denver 7
Hangzhou 7
Napoli 7
Padova 7
Poplar 7
Redwood City 7
Tianjin 7
Tokyo 7
Amsterdam 6
Bologna 6
Brussels 6
Dhaka 6
Düsseldorf 6
Totale 8.485
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.197
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 300
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 288
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 277
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 271
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options 269
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 268
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 262
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 256
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 253
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 248
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 243
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 239
HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 231
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes 229
Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 226
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 224
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 223
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 218
Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus 211
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 210
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 204
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 201
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 199
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients 198
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 195
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC 193
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 189
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 188
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 180
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 180
Non-coding RNAs: novel players in insulin resistance and related diseases 177
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 176
Fighting diabetic foot ulcers—The diabetologist: A king maker of the fight 175
12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients 173
The case for virus-induced type 1 diabetes 172
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 172
La prevenzione del diabete mellito di tipo 1 166
Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study 165
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors 164
SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature 160
Microbioma intestinale e diabete mellito 147
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation 144
Il ruolo del laboratorio nella valutazione dell'insulino-resistenza. 133
Environmental factors in the development of diabetes mellitus 132
Erectile dysfunction and diabetes: association with the impairment of lipid metabolism and oxidative stress. 128
12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes 125
Extracellular vesicles in immune system regulation and Type 1 diabetes: cell-to-cell communication Mediators, disease biomarkers, and promising therapeutic tools 119
Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples 117
null 114
CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes 112
null 109
MicroRNAs: Novel players in the dialogue between pancreatic islets and immune system in autoimmune diabetes 109
null 106
Real-world use of oral versus subcutaneous semaglutide in a cohort of type 2 diabetic patients: which option to which patient? 104
The impact of environmental pollution on metabolic health and the risk of non-communicable chronic metabolic diseases in humans 87
Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child 86
null 85
null 79
Editorial: The contribution of viruses and innate immune system in the pathogenesis of type 1 diabetes 72
Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes 70
Hyperglycemia and diabetes induced by glucocorticoids in nondiabetic and diabetic patients: Revision of literature and personal considerations 56
Towards an Earlier and Timely Diagnosis of Type 1 Diabetes: Is it Time to Change Criteria to Define Disease Onset? 46
Adherence to the mediterranean diet and risk of hypoglycemia in insulin-treated type 2 diabetic patients 45
Totale 12.095
Categoria #
all - tutte 34.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021699 0 0 0 0 0 89 82 142 89 137 69 91
2021/2022660 59 83 44 78 25 20 31 24 31 52 79 134
2022/20231.014 47 106 94 107 113 223 24 72 81 54 56 37
2023/20241.023 36 43 101 61 52 253 291 33 14 50 15 74
2024/20251.977 42 108 226 125 277 128 74 104 198 84 175 436
2025/20264.126 327 572 1.638 611 919 59 0 0 0 0 0 0
Totale 12.095